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Abstract: A simple and rapid diagnostic method of Anaplasma phagocytophilum infection was established, employing 
the loop-mediated isothermal amplifi cation (LAMP) reaction. With 1 set of 4 specifi c primers targeting the citrate 
synthase (gltA) gene of A. phagocytophilum, the LAMP assay rapidly amplifi ed the target DNA sequence in a single tube 
in 1 h, requiring only a water bath for reaction. When visualized by gel electrophoresis, the LAMP products appeared as 
a ladder-like pattern, with many bands of diff erent sizes from 180 base pairs up to the loading well. Th e results obtained 
from testing 32 clinical blood samples of dogs demonstrated that the LAMP method was more sensitive than nested 
PCR in the diagnosis reaction for the detection of A. phagocytophilum DNA. 
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Anaplasma phagocytophilum (Rickettsiales: 
Anaplasmataceae), formerly known as the human 
granulocytic ehrlichiosis (HGE) agent, Ehrlichia equi, 
and Ehrlichia phagocytophila, is the causative agent of 
granulocytic anaplasmosis (1). In humans, the disease 
is characterized by fever, headache, myalgia, malaise, 
leukopenia, thrombocytopenia, and evidence of 
hepatic injury (2,3). Tick-borne fever is reported as 
a febrile disease of cows, deer, hares, and sheep, with 
clinical signs varying from undetectable illness to 
severe febrile disease associated with opportunistic 
infections (4). Equine and canine diseases are 
characterized by fever, depression, anorexia, 
leukopenia, and thrombocytopenia. Equine infection 
also frequently results in limb edema and ataxia and 
may lead to opportunistic infections (4,5).
Laboratory techniques used to diagnose A. 
phagocytophilum infection include primary isolation 
by culture, microscopic identifi cation of morulae 
in stained blood smears, serology, and molecular 
methods. Although isolation is the “gold standard” for 
diagnosis, cultivation entails prolonged incubation 
and requires a level of technical expertise not likely 
to be found in most laboratories (6). Th e recognition 
of morulae in infected cells during the examination 
of stained blood smears can be diagnostic. However, 
morulae have not been observed in several cases 
subsequently confi rmed by other criteria (7). 
Serological methods are commonly used, but these 
assays are oft en negative in the early acute phase 
of the illness, as antibody will typically be absent 
during the fi rst week of infection (8). Furthermore, 
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serological cross-reactions may occur between closely 
related organisms, leading to misinterpretation and 
misdiagnosis (9). With the recent development of 
molecular biology methods, specifi c and sensitive 
assays such as polymerase chain reaction (PCR) and 
nucleotide sequencing are now used for the detection 
of A. phagocytophilum in clinical and fi eld-collected 
samples (10-14). 
Notomi et al. (15) previously described a 
novel method, termed loop-mediated isothermal 
amplifi cation (LAMP), which can amplify DNA 
with high specifi city, effi  ciency, and rapidity. Th e 
aim of this study was to establish a LAMP-based 
A. phagocytophilum DNA amplifi cation technique 
and examine its applicability and reliability for the 
diagnosis of granulocytic anaplasmosis caused by A. 
phagocytophilum. 
Ethylenediaminetetraacetic acid (EDTA)-treated 
blood samples used in the present study were 
collected from 32 dogs, clinically suspected of being 
A. phagocytophilum-infected, that were referred to 
the Veterinary Teaching Hospital of National Chung 
Hsing University and 8 veterinary clinics throughout 
Taiwan between 2007 and 2010. For each sample, 
DNA was extracted from 200 μL of whole blood by 
using the QIAamp DNA Blood Mini kit (Qiagen), 
according to the instructions of the manufacturer. 
Th e extracted DNA was eluted in a total volume of 
100 μL of elution buff er and was stored at –20 °C 
until further use. 
In the initial study, a species-specifi c nested 
polymerase chain reaction (PCR) was used to 
identify samples infected with A. phagocytophilum. 
Oligonucleotide primers used for nested PCR were 
designed, based on the citrate synthase (gltA) gene 
sequence of A. phagocytophilum (accession numbers 
AF304136 to AF304138 and AY464132 to AY464138, 
DQ160228, and AY339602 in GenBank) aft er 
comparing the alignment of gltA gene sequences from 
other genetically related rickettsia (Anaplasma platys, 
AY077620, AF058782, AF478130, and AY530807; 
Anaplasma marginale, AF304140; Anaplasma 
centrale, AF304141; Ehrlichia ewingii, DQ365879; 
Ehrlichia canis, AF304143; Ehrlichia chaff eensis, 
AF304142; Ehrlichia muris, AF304144; Ehrlichia 
ruminantium, AF304146; and Neorickettsia risticii, 
AF304147) (16). Th e name, location, and sequence 
of each primer are given in Figure 1. Th e specifi cities 
of the designed primers were initially checked using 
the Basic Local Alignment Search Tool (BLAST) 
program on the National Center for Biotechnology 
Information server (http://www.ncbi.nlm.nih.gov/) 
before being confi rmed by the assays. Th e fi rst 
round of PCR amplifi cation was carried out in a 25-
μL reaction mixture containing 1 μM each of the 
primers Aph-F4 and Aph-B4, 0.2 mM of each dNTPs, 
1 × Taq buff er (Invitrogen), 2.5 mM MgCl2, 2 μL of 
template DNA, and 1.25 U of Taq DNA polymerase 
(Invitrogen). Th e amplifi cation was performed in 
capillary tubes using the Gene Amp PCR system 
9700 thermal cycler (Applied Biosystems) with the 
following program: an initial 5 min denaturation at 
94 °C; 35 repeated cycles of denaturation (94 °C for 
1 min), annealing (57 °C for 30 s), and extension (72 
°C for 30 s); followed by 5 min extension at 72 °C. 
Distilled water (no template) and DNA extracted 
from the blood sample of a healthy dog were 
included as negative controls. Aft er electrophoresis 
on 1% agarose gel, the amplifi cation products were 
visualized by ethidium bromide staining under UV 
fl uorescence. As several non-specifi c bands were 
observed in the fi rst PCR (data not shown), it was 
diffi  cult to evaluate the results. Th en the fi rst-round 
PCR product from each sample was diluted 1 to 5 
with distilled water and 2 μL of the diluted solution 
was used as the template DNA for the second round 
of PCR with primers Aph-F3 and Aph-B3 (see Figure 
1) to amplify a 221-bp fragment. Th e annealing step 
was performed at 55 °C for 30 s. Th e other PCR 
conditions were the same as in the fi rst-round PCR. 
Th e amplifi cation products were visualized on a 1% 
agarose gel aft er electrophoretic migration. As shown 
in Figure 2, in all of the infected samples (lanes 2-5), 
the expected 221-bp band is obvious.
To further confi rm the specifi city of the PCR 
method, an amplifi cation product  chosen randomly 
from 21 PCR-positive samples was purifi ed with 
an MinElute Gel Extraction kit (Qiagen) and then 
subjected to direct sequence analysis using the Big 
Dye Terminator kit (Applied Biosystems) with an 
automated DNA sequencer (ABI PRISM 310 genetic 
analyzer). Th e sequence data of the PCR product 
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were analyzed by BLAST for the homology search. 
Th e result showed that the 181-bp fragment of the 
positive PCR excluding the primer regions was 100% 
homologous to the registered gltA gene sequence of 
A. phagocytophilum (GenBank accession numbers 
AF304137 and AF304138) (16). Th us, the genomic 
DNA extracted from this blood sample was used 
as a positive control to determine the appropriate 
conditions for the A. phagocytophilum-specifi c 
LAMP assay. 
During the development of a LAMP assay, we 
evaluated the specifi city of the A. phagocytophilum-
specifi c LAMP primers fi rst. Th e primers used for 
LAMP amplifi cations were designed according 
to the nucleotide sequence of the gltA gene of A. 
phagocytophilum (16) (see Figure 1 for detailed 
sequences). Th e LAMP method requires a set of 
4 specially designed primers, 2 outer and 2 inner, 
which recognize 6 distinct regions on the target 
sequence (15). Th e outer primers for LAMP (F3 and 
B3) were the same as the inner primers for nested 
PCR. Th e inner primers for LAMP were denoted 
as forward inner primer (FIP) and backward inner 
primer (BIP). Th e FIP consisted of a complementary 
Figure 1. Oligonucleotide primers of LAMP for the detection of A. phagocytophilum. Nucleotide sequence of 
the gltA gene of A. phagocytophilum (GenBank accession number AF304138) was used as target. 
Th e nucleotide sequences and the positions used to design the primers are shadowed and labeled. 
Numbers indicate the nucleotide positions. Th e outer primers for LAMP (F3 and B3) were the same as 
the inner primers for nested PCR. F1c, sequence complementary to F1; B1c, sequence complementary 
to B1. 
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sequence of F1 (F1c) and a sense sequence of F2. Th e 
BIP consisted of a complementary sequence of B1 
(B1c) and a sense sequence of B2. 
Th e LAMP reaction was carried out in 25 μL of 
a mixture containing 5 μL of the extracted DNA, 
0.2 μM each of outer primers Aph-F3 and Aph-B3, 
1.6 μM each of inner primers Aph-FIP and Aph-
BIP, 1.4 mM each dNTP, 0.8 M betaine (Sigma-
Aldrich), 20 mM Tris-HCl (pH 8.8), 10 mM KCl, 
10 mM (NH4)2SO4, 8 mM MgSO4, 0.1% Tween 20, 
and 8 U of the Bst DNA polymerase large fragment 
(New England Biolabs). Th e mixture was incubated 
at 65 °C for 60 min using a conventional water bath 
and was heated at 80 °C for 5 min to terminate the 
reaction. From each of the amplifi ed products, 5 μL 
was analyzed by electrophoresis on 1.5% agarose gel, 
followed by ethidium bromide staining, visualization 
on a UV transilluminator, and photography. Distilled 
water and DNAs extracted from the A. platys-, E. 
canis-, and Babesia gibsoni-positive blood samples 
were included as negative controls. Due to the 
formation of stem-loop DNAs of varying stem 
length and caulifl ower-like structures with multiple 
loops formed by sequentially inverted repeats of the 
target sequence, the LAMP product of the positive 
sample demonstrated many bands of diff erent sizes 
upon agarose gel electrophoresis (15,17). As shown 
in Figure 3, the amplifi ed A. phagocytophilum DNA 
exhibited a typical ladder-like pattern on the gel 
(lane 2), whereas no LAMP product was detected in 
reactions performed with any of other DNAs (lane 
3-6). Th ese results indicated that the LAMP assay 
had high specifi city among DNA samples we tested. 
M          1            2             3             4           5              6
bp
300
200
Figure 2. An ethidium bromide-stained agarose gel showing the 
nested PCR products amplifi ed from blood samples of 
clinically A. phagocytophilum-suspected dogs. Lanes 
2-5, the samples from naturally infected dogs; lane 1, 
no template DNA; lane 6, the sample from a healthy 
dog (negative control); and lane M, 100-bp DNA 
ladder marker.
M           1               2               3              4              5               6
Figure 3. Specifi city of LAMP primers for detection of A. 
phagocytophilum. DNAs were extracted from 200-μL 
blood samples of dogs infected by diff erent rickettsia 
(lane 2, A. phagocytophilum; lane 3, A. platys; lane 4, 
E. canis; and lane 5, B. gibsoni) and were resuspended 
in 100 μL of buff er. An aliquot of 2 μL was subjected to 
LAMP. Th e LAMP products were electrophoresed on 
1.5% agarose gel and stained with ethidium bromide. 
Lane 1, no template DNA; lane 6, the sample from a 
healthy dog (negative control); and lane M, 100-bp 
DNA ladder marker.  
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Th e sensitivity of the LAMP method was also 
determined and compared with that of the gltA 
nested PCR method as described above and that of 
the PCR method using the epank1 primers designed 
in a previous study (14). An A. phagocytophilum-
positive dog blood sample with approximately 6% 
parasitemia was subjected to 10-fold dilutions using 
normal dog blood, and DNA extracted from each 
diluted sample was used to determine the detection 
limit of each method. Th e results shown in Figure 4 
indicated that the sensitivities of the LAMP and gltA 
nested PCR methods were equivalent, with detection 
limits of 0.000006% parasitemia each (lane 7). At this 
level of dilution, however, the positive LAMP result 
could be easily determined by visual examination of 
the DNA smear and the pattern of many DNA bands 
of diff erent sizes. In contrast, the positive gltA PCR 
result only showed a very faint single band. Th ese 2 
methods had detection limits 10-fold lower than that 
for the epank1 PCR method.
Aft er these initial validation studies, 32 blood 
samples of clinically A. phagocytophilum-suspected 
dogs were tested for A. phagocytophilum by LAMP 
and nested PCR simultaneously. With LAMP, 23 of 
the 32 blood samples (71.9%) tested positive, whereas 
21 of the 32 blood samples (65.6%) tested positive by 
nested PCR. When tested by both LAMP and nested 
PCR, 21 blood samples (65.6%) were positive, while 2 
samples (6.3%) were positive by LAMP and negative 
by nested PCR. No sample that tested positive by 
nested PCR tested negative by LAMP; and 9 samples 
(28.1%) tested negative by both tests. Th e agreement 
between the 2 tests was 91.3%. None of the blood 
samples obtained from 8 adult dogs exhibiting no 
clinical signs of tick-borne diseases were positive by 
either one of tests, thereby indicating the specifi city 
of the 2 assay systems. 
In summary, a novel A. phagocytophilum DNA 
detection system has been developed employing 
the nucleic acid amplifi cation method, LAMP. Th e 
LAMP assay described here is quite simple; it is 
performed in a single tube, incubating the mixture 
at a constant 65 °C for 1 h in an ordinary water bath. 
Th e advantages of the method are due to its simple 
operation, rapid reaction, and potential for visual 
interpretation without instrumentation. Although 
limited numbers of clinical samples were used in 
the present study, it has been shown that LAMP 
could be useful as an on-site diagnostic assay for 
detecting A. phagocytophilum infection. As a result, 
the LAMP assay is expected to be a valuable tool 
for epidemiologic studies that require screening 
of large numbers of potential vector and reservoir 
populations for A. phagocytophilum.
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Figure 4. Relative sensitivities of LAMP and PCR for detection 
of A. phagocytophilum. Th e DNA extracted from an A. 
phagocytophilum-positive dog blood sample with 6% 
parasitemia was subjected to serial 10-fold dilutions 
from 100 to 10-8 (lanes 1-9, respectively). Th ose diluted 
DNA samples were used to carry out the amplifi cation 
reaction, followed by agarose gel electrophoresis, to 
determine the lowest detection limit of the method. 
Th e amplifi cation by LAMP (top) showed a ladder-like 
pattern, whereas the gltA nested PCR (middle) and the 
epank1 PCR (bottom) showed a 221-bp amplicon and 
a 444-bp amplicon, respectively. Lane M, 100-bp DNA 
ladder marker.
A loop-mediated isothermal amplifi cation (LAMP) assay for rapid detection of Anaplasma phagocytophilum infection in dogs  
210
References
1.  Dumler, J.S., Barbet, A.F., Bekker, C.P., Dasch, G.A., Palmer, 
G.H., Ray, S.C., Rikihisa, Y., Rurangirwa, F.R.: Reorganization of 
the genera in the families Rickettsiaceae and Anaplasmataceae 
in the order Rickettsiales: unifi cation of some species of 
Ehrlichia with Anaplasma, Cowdria with Ehrlichia and 
Ehrlichia with Neorickettsia, descriptions of six new species 
combinations and designation of Ehrlichia equi and ‘HGE 
agent’ as subjective synonyms of Ehrlichia phagocytophila. Int. 
J. Syst. Evol. Microbiol., 2001; 51: 2145-2165.
2.  Aguero-Rosenfeld, M.E., Horowitz, H.W., Wormser, G.P., 
McKenna, D.F., Nowakowski, J., Muñoz, J., Dumler, J.S.: 
Human granulocytic ehrlichiosis: a case series from a medical 
center in New York State. Ann. Intern. Med., 1996; 125: 904-
908.
3.  Chen, S.M., Dumler, J.S., Bakken, J.S., Walker, D.H.: 
Identifi cation of a granulocytotropic Ehrlichia species as the 
etiologic agent of human disease. J. Clin. Microbiol., 1994; 32: 
589-595.
4.  McDade, J.E.: Ehrlichiosis-a disease of animals and humans. J. 
Infect. Dis., 1990; 161: 609-617.
5.  M’Ghirbi, Y., Ghorbel, A., Amouri, M., Nelaoui, A., Haddad, 
S., Bouattour, A.: Clinical, serological, and molecular evidence 
of ehrlichiosis and anaplasmosis in dogs in Tunisia. Parasitol. 
Res., 2009; 104: 767-774.
6.  Goodman, J.L., Nelson, C., Vitale, B., Madigan, J.E., Dumler, 
J.S., Kurtti, T.J., Munderloh, U.G.: Direct cultivation of the 
causative agent of human granulocytic ehrlichiosis. N. Engl. J. 
Med., 1996; 334: 209-215.
7.  Lester, S.J., Breitschwerdt, E.B., Collis, C.D., Hegarty, 
B.C.: Anaplasma phagocytophilum infection (granulocytic 
anaplasmosis) in a dog from Vancouver Island. Can. Vet. J., 
2005; 46: 825-827.
8. Yeh, M.T., Mather, T.N., Coughlin, R.T., Gingrich-Baker, C., 
Sumner, J.W., Massung, R.F.: Serologic and molecular detection 
of granulocytic ehrlichiosis in Rhode Island. J. Clin. Microbiol., 
1997; 35: 944-947.
9.   Keysary, A., Amram, L., Keren, G., Sthoeger, Z., Potasman, 
I., Jacob, A., Strenger, C., Dawson, J.E., Waner, T.: Serologic 
evidence of human monocytic and granulocytic ehrlichiosis in 
Israel. Emerg. Infect. Dis., 1999; 5: 775-778.
10.  Edelman, D.C., Dumler, J.S.: Evaluation of an improved PCR 
diagnostic assay for human granulocytic ehrlichiosis. Mol. 
Diagn., 1996; 1: 41-49.
11.  Massung, R.F., Slater, K.G.: Comparison of PCR assays for 
detection of the agent of human granulocytic ehrlichiosis, 
Anaplasma phagocytophilum. J. Clin. Microbiol., 2003; 41: 717-
722.
12.  Dumler, J.S., Brouqui, P.: Molecular diagnosis of human 
granulocytic anaplasmosis. Expert Rev. Mol. Diagn., 2004; 4: 
559-569.
13.  Hulinska, D., Langrova, K., Pejcoch, M., Pavlasek, I.: Detection 
of Anaplasma phagocytophilum in animals by real-time 
polymerase chain reaction. APMIS, 2004; 112: 239-247.
14.  Walls, J.J., Caturegli, P., Bakken, J.S., Asanovich, K.M., Dumler, 
J.S.: Improved sensitivity of PCR for diagnosis of human 
granulocytic ehrlichiosis using epank1 genes of Ehrlichia 
phagocytophila-group ehrlichiae. J. Clin. Microbiol., 2000; 38: 
354-356.
15.  Notomi, T., Okayama, H., Masubuchi, H., Yonekawa, T., 
Watanabe, K., Amino, N., Hase, T.: Loop-mediated isothermal 
amplifi cation of DNA. Nucleic Acids Res., 2000; 28: E63.
16.  Inokuma, H., Brouqui, P., Drancourt, M., Raoult, D.: Citrate 
synthase gene sequence: a new tool for phylogenetic analysis 
and identifi cation of Ehrlichia. J. Clin. Microbiol., 2001; 39: 
3031-3039.
17.  Nagamine, K., Watanabe, K., Ohtsuka, K., Hase, T., Notomi, 
T.: Loop-mediated isothermal amplifi cation reaction using a 
nondenatured template. Clin. Chem., 2001; 47: 1742-1743.
